Product overview

  • Name
  • Short description
    L-type voltage gated calcium channel blocker
  • Biological description
    L-type voltage gated calcium channel blocker (EC50 = 1.4 nM). Highest affinity for Cav1.3 and Cav1.2 channels over Cav1.4. Displays neuroprotective properties. Blood brain barrier permeable.
  • Biological action
  • Purity
  • Our products in action


  • Chemical name
    4-(2,1,3-Benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinecarboxylic acid methyl 1-methylethyl ester
  • Molecular Weight
  • Chemical structure
    Isradipine  [75695-93-1]
  • Molecular Formula
  • CAS Number

Storing and Using Your Product

  • Storage instructions
    room temperature
  • Solubility overview
    soluble in DMSO (50mM) or ethanol (20mM)
  • Important
    This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use.

References for Isradipine

  • The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease.

    Ilijic E et al (2011) Neurobiol Dis 43(2) : 364-71.
    PubMedID: 21515375
  • Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms.

    Sinnegger-Brauns MJ et al (2009) Mol Pharmacol 75(2) : 407-14.
    PubMedID: 19029287
  • L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer's disease.

    Anekonda TS et al (2011) Neurobiol Dis 41(1) : 62-70.
    PubMedID: 20816785
  • PN 200-110, a new calcium antagonist: electrophysiological, inotropic, and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta.

    Hof RP et al (1984) J Cardiovasc Pharmacol 6(3) : 399-406.
    PubMedID: 6202964

Reviews & Product Guides